These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 21552566)

  • 1. Variation in the FFAR1 gene modifies BMI, body composition and beta-cell function in overweight subjects: an exploratory analysis.
    Walker CG; Goff L; Bluck LJ; Griffin BA; Jebb SA; Lovegrove JA; Sanders TA; Frost GS;
    PLoS One; 2011 Apr; 6(4):e19146. PubMed ID: 21552566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reevaluation of fatty acid receptor 1 as a drug target for the stimulation of insulin secretion in humans.
    Wagner R; Kaiser G; Gerst F; Christiansen E; Due-Hansen ME; Grundmann M; Machicao F; Peter A; Kostenis E; Ulven T; Fritsche A; Häring HU; Ullrich S
    Diabetes; 2013 Jun; 62(6):2106-11. PubMed ID: 23378609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variants in the FFAR1 gene are associated with beta cell function.
    Kalis M; Levéen P; Lyssenko V; Almgren P; Groop L; Cilio CM
    PLoS One; 2007 Nov; 2(11):e1090. PubMed ID: 17987108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Point mutation of Ffar1 abrogates fatty acid-dependent insulin secretion, but protects against HFD-induced glucose intolerance.
    Sabrautzki S; Kaiser G; Przemeck GKH; Gerst F; Lorza-Gil E; Panse M; Sartorius T; Hoene M; Marschall S; Häring HU; Hrabě de Angelis M; Ullrich S
    Mol Metab; 2017 Oct; 6(10):1304-1312. PubMed ID: 29031729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of free fatty acid receptor 1 expression in pancreatic β-cells in obese type 2 diabetic db/db mice: a potential role of pancreatic and duodenal homeobox factor 1.
    Kohara K; Obata A; Kimura T; Shimoda M; Moriuchi S; Okauchi S; Hirukawa H; Mune T; Kaku K; Kaneto H
    Endocr J; 2019 Jan; 66(1):43-50. PubMed ID: 30333365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Common genetic variants highlight the role of insulin resistance and body fat distribution in type 2 diabetes, independent of obesity.
    Scott RA; Fall T; Pasko D; Barker A; Sharp SJ; Arriola L; Balkau B; Barricarte A; Barroso I; Boeing H; Clavel-Chapelon F; Crowe FL; Dekker JM; Fagherazzi G; Ferrannini E; Forouhi NG; Franks PW; Gavrila D; Giedraitis V; Grioni S; Groop LC; Kaaks R; Key TJ; Kühn T; Lotta LA; Nilsson PM; Overvad K; Palli D; Panico S; Quirós JR; Rolandsson O; Roswall N; Sacerdote C; Sala N; Sánchez MJ; Schulze MB; Siddiq A; Slimani N; Sluijs I; Spijkerman AM; Tjonneland A; Tumino R; van der A DL; Yaghootkar H; ; ; McCarthy MI; Semple RK; Riboli E; Walker M; Ingelsson E; Frayling TM; Savage DB; Langenberg C; Wareham NJ
    Diabetes; 2014 Dec; 63(12):4378-4387. PubMed ID: 24947364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma free fatty acids do not provide the link between obesity and insulin resistance or β-cell dysfunction: results of the Reading, Imperial, Surrey, Cambridge, Kings (RISCK) study.
    Johns I; Goff L; Bluck LJ; Griffin BA; Jebb SA; Lovegrove JA; Sanders TA; Frost G; Dornhorst A
    Diabet Med; 2014 Nov; 31(11):1310-5. PubMed ID: 25047698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 20-HETE promotes glucose-stimulated insulin secretion in an autocrine manner through FFAR1.
    Tunaru S; Bonnavion R; Brandenburger I; Preussner J; Thomas D; Scholich K; Offermanns S
    Nat Commun; 2018 Jan; 9(1):177. PubMed ID: 29330456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of GPR40/FFAR1 does not induce diabetes even under insulin resistance condition.
    Matsuda-Nagasumi K; Takami-Esaki R; Iwachidow K; Yasuhara Y; Tanaka H; Ogi K; Nakata M; Yano T; Hinuma S; Taketomi S; Odaka H; Kaisho Y
    Diabetes Obes Metab; 2013 Jun; 15(6):538-45. PubMed ID: 23331570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma complement C3 levels are associated with insulin secretion independently of adiposity measures in non-diabetic individuals.
    Fiorentino TV; Hribal ML; Andreozzi F; Perticone M; Sciacqua A; Perticone F; Sesti G
    Nutr Metab Cardiovasc Dis; 2015 May; 25(5):510-7. PubMed ID: 25813686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Several genetic polymorphisms interact with overweight/obesity to influence serum lipid levels.
    Yin RX; Wu DF; Miao L; Aung LH; Cao XL; Yan TT; Long XJ; Liu WY; Zhang L; Li M
    Cardiovasc Diabetol; 2012 Oct; 11():123. PubMed ID: 23039238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AMPK Subunits Harbor Largely Nonoverlapping Genetic Determinants for Body Fat Mass, Glucose Metabolism, and Cholesterol Metabolism.
    Randrianarisoa E; Lehn-Stefan A; Krier J; Böhm A; Heni M; Hrabě De Angelis M; Fritsche A; Häring HU; Stefan N; Staiger H
    J Clin Endocrinol Metab; 2020 Jan; 105(1):. PubMed ID: 31512724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Palmitic acid-induced lipotoxicity promotes a novel interplay between Akt-mTOR, IRS-1, and FFAR1 signaling in pancreatic β-cells.
    Marafie SK; Al-Shawaf EM; Abubaker J; Arefanian H
    Biol Res; 2019 Aug; 52(1):44. PubMed ID: 31426858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of FFAR1/GPR40 does not protect mice from high-fat diet-induced metabolic disease.
    Lan H; Hoos LM; Liu L; Tetzloff G; Hu W; Abbondanzo SJ; Vassileva G; Gustafson EL; Hedrick JA; Davis HR
    Diabetes; 2008 Nov; 57(11):2999-3006. PubMed ID: 18678612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of extracellular signal-regulated protein kinases 1 and 2 (ERK1/2) by free fatty acid receptor 1 (FFAR1/GPR40) protects from palmitate-induced beta cell death, but plays no role in insulin secretion.
    Panse M; Gerst F; Kaiser G; Teutsch CA; Dölker R; Wagner R; Häring HU; Ullrich S
    Cell Physiol Biochem; 2015; 35(4):1537-45. PubMed ID: 25792236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic, hormonal characteristics and genetic variants of TCF7L2 associated with development of gestational diabetes mellitus in Mexican women.
    Reyes-López R; Pérez-Luque E; Malacara JM
    Diabetes Metab Res Rev; 2014 Nov; 30(8):701-6. PubMed ID: 24639413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss-of-function mutation of the GPR40 gene associates with abnormal stimulated insulin secretion by acting on intracellular calcium mobilization.
    Vettor R; Granzotto M; De Stefani D; Trevellin E; Rossato M; Farina MG; Milan G; Pilon C; Nigro A; Federspil G; Vigneri R; Vitiello L; Rizzuto R; Baratta R; Frittitta L
    J Clin Endocrinol Metab; 2008 Sep; 93(9):3541-50. PubMed ID: 18583466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Situation of impaired glucose regulation and metabolic syndrome in overweight or obesity adolescent students in Dongguan city].
    Peng YQ; Nie WM; Chen JG; Tang HM; Cao T; Lin YX
    Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Jun; 43(6):495-500. PubMed ID: 19950716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of supervised progressive resistance-exercise training protocol on insulin sensitivity, glycemia, lipids, and body composition in Asian Indians with type 2 diabetes.
    Misra A; Alappan NK; Vikram NK; Goel K; Gupta N; Mittal K; Bhatt S; Luthra K
    Diabetes Care; 2008 Jul; 31(7):1282-7. PubMed ID: 18316394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations of total and undercarboxylated osteocalcin with peripheral and hepatic insulin sensitivity and β-cell function in overweight adults.
    Gower BA; Pollock NK; Casazza K; Clemens TL; Goree LL; Granger WM
    J Clin Endocrinol Metab; 2013 Jul; 98(7):E1173-80. PubMed ID: 23616149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.